Mid*Lands IRB
, LLC is pleased to announce that it has been awarded accreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) at the September meeting of its Council on Accreditation.
Located in the Kansas City metro area, Mid*Lands is an independent review board (IRB) that protects the rights and welfare of research study participants. Mid*Lands IRB specializes in providing customized, personalized, and responsive services for its client partners. Mid*Lands provides IRB review for clients nationwide for all phases of research in all therapeutic areas. Mid*Lands has extensive experience in multi-site trials, with two Boards that meet weekly.
AAHRPP promotes high-quality research through an accreditation process that helps organizations worldwide strengthen their human research protection programs (HRPPs).
An independent, non-profit accrediting body, AAHRPP uses a voluntary, peer-driven, educational model to ensure that HRPPs meet rigorous standards for quality and protection. To earn accreditation, organizations must provide tangible evidence through policies, procedures, and practices of their commitment to scientifically and ethically sound research and continuous improvement.
As the "gold seal," AAHRPP accreditation offers assurances to research participants, researchers, sponsors, government regulators, and the general public that an HRPP is focused first and foremost on excellence.
"After a tremendous amount of work by both our staff and our IRB Members, Mid*Lands has achieved full accreditation," according to Cathy Owen, CIM, CIP, CCRP, President and CEO of Mid*lands. "The rigorous and comprehensive accreditation mandated by AAHRPP provides Mid*Lands with the ability to achieve even higher levels of protection for human research participants," Ms. Owen said.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.